Literature DB >> 239064

Transplantation immunology of the anterior chamber of the eye. I. An intra-ocular graft-vs-host reaction (immunogenic anterior uveitis).

H J Kaplan, T R Stevens, J W Streilein.   

Abstract

A graft-vs-host reaction (GVHR) expressed as an anterior uveitis was elicited within the anterior chambers of the eyes of F1 hybrid rats by the inoculation of suspensions of allogeneic, parental lymph node cells. This response resembled local GVHRs induced in other sites, except for the failure of refractoriness to appear following resolution of the acute phase. Because lymphoid cells within the anterior chamber have been shown to leave and make an impact on the systemic immunologic apparatus of the recipient, rather than remain isolated within the eye, it was suggested that the vascular route by which these cells disseminate is an important determinant of whether refractoriness will ensue from a local GVHR.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239064

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Immunologic privilege of the eye.

Authors:  J W Streilein
Journal:  Springer Semin Immunopathol       Date:  1999

2.  CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity.

Authors:  Michael G Strainic; Jinbo Liu; Fengqi An; Erin Bailey; Andrew Esposito; Jörg Hamann; Peter S Heeger; M Edward Medof
Journal:  Am J Pathol       Date:  2019-05-17       Impact factor: 4.307

Review 3.  Negative regulators that mediate ocular immune privilege.

Authors:  Andrew W Taylor; Tat Fong Ng
Journal:  J Leukoc Biol       Date:  2018-02-12       Impact factor: 4.962

4.  Rabbit immunization to xenogeneic red blood cells following anterior eye chamber inoculation.

Authors:  M W Dennis
Journal:  Experientia       Date:  1984-03-15

5.  Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?

Authors:  Jerry Y Niederkorn
Journal:  Front Immunol       Date:  2012-06-13       Impact factor: 7.561

Review 6.  The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy.

Authors:  Jean-Pierre Routy; Bertrand Routy; Gina M Graziani; Vikram Mehraj
Journal:  Int J Tryptophan Res       Date:  2016-10-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.